Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N-terminus of HIV-1 Tat indicate at least two inhibitor binding sites.
Lorey S, Stöckel-Maschek A, Faust J, Brandt W, Stiebitz B, Gorrell MD, Kähne T, Mrestani-Klaus C, Wrenger S, Reinhold D, Ansorge S, Neubert K.
Eur J Biochem. 2003 May;270(10):2147-56.
Related citations
The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growth.
Wrenger S, Hoffmann T, Faust J, Mrestani-Klaus C, Brandt W, Neubert K, Kraft M, Olek S, Frank R, Ansorge S, Reinhold D.
J Biol Chem. 1997 Nov 28;272(48):30283-8.
The N-terminal X-X-Pro sequence of the HIV-1 Tat protein is important for the inhibition of dipeptidyl peptidase IV (DP IV/CD26) and the suppression of mitogen-induced proliferation of human T cells.
Wrenger S, Reinhold D, Hoffmann T, Kraft M, Frank R, Faust J, Neubert K, Ansorge S.
FEBS Lett. 1996 Apr 1;383(3):145-9.
Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity.
Gutheil WG, Subramanyam M, Flentke GR, Sanford DG, Munoz E, Huber BT, Bachovchin WW.
Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6594-8.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on